{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:31:35Z","timestamp":1786116695046,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10620-026-09776-y","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:44:21Z","timestamp":1772077461000},"page":"3113-3120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Using the EVendo Score to Predict Varices and Varices Needing Treatment in Hepatocellular Carcinoma Patients Planned for Atezolizumab-Bevacizumab"],"prefix":"10.1007","volume":"71","author":[{"given":"Suat Ying","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiew Woon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umairah Binte Abdul","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy Yao Yi","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Pik-Eu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Wai-Meng","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhoon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joycelyn Jie Xin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"9776_CR1","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. New Engl J Med 2020;382:1894\u20131905.","journal-title":"New Engl J Med"},{"key":"9776_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102179","volume":"30","author":"AV Kulkarni","year":"2023","unstructured":"Kulkarni AV, Tevethia H, Kumar K, Premkumar M, Muttaiah MD, Hiraoka A, Hatanaka T, Tada T, Kumada T, Kakizaki S, Vogel A, Finn RS, Rao PN, Pillai A, Reddy DN, Singal AG. Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis. EClinicalMedicine. 2023;30:102179.","journal-title":"EClinicalMedicine."},{"key":"9776_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R, Faculty Baveno VI. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Work- shop: stratifying risk and individualizing care for portal hyper- tension. J Hepatol 2015;63:743\u2013752.","journal-title":"J Hepatol"},{"key":"9776_CR4","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3389\/fphys.2019.01028","volume":"13","author":"Z Szak\u00e1cs","year":"2019","unstructured":"Szak\u00e1cs Z, Er\u0151ss B, So\u00f3s A, M\u00e1trai P, Szab\u00f3 I, P\u00e9terv\u00e1ri E, Bajor J, Farkas N, Hegyi P, Ill\u00e9s A, Solym\u00e1r M, Balask\u00f3 M, Sarl\u00f3s P, Sz\u0171cs \u00c1, Czimmer J, Vincze \u00c1, P\u00e1r G. Baveno criteria safely identify patients with compensated advanced chronic liver disease who can avoid variceal screening endoscopy: a diagnostic test accuracy meta-analysis. Front Physiol. 2019;13:1028.","journal-title":"Front Physiol."},{"key":"9776_CR5","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.cgh.2019.01.025","volume":"17","author":"TS Dong","year":"2019","unstructured":"Dong TS, Kalani A, Aby ES et al. Machine learning-based development and validation of a scoring system for screening high-risk esophageal varices. Clin Gastroenterol Hepatol 2019;17:1894-1901.e1891.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9776_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4103\/sjg.sjg_624_21","volume":"28","author":"K Alswat","year":"2022","unstructured":"Alswat K, Alanazi M, Bashmail A, Alkhamash M, Alqahtani SA, Al-Hamoudi W, Abdo AA. Validation of the EVendo score for the prediction of varices in cirrhotic patients. Saudi J Gastroenterol. 2022;28:378\u2013384.","journal-title":"Saudi J Gastroenterol."},{"key":"9776_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/HEP.0000000000001269","volume":"82","author":"Tamar H Taddei","year":"2025","unstructured":"Taddei Tamar H, Brown Daniel B, Yarchoan Mark, Mendiratta-Lala Mishal, Llovet Josep M. Critical update: AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 2025;82:272\u2013274.","journal-title":"Hepatology"},{"key":"9776_CR8","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.3390\/cancers16162878","volume":"16","author":"CL Lee","year":"2024","unstructured":"Lee CL, Freeman M, Burak KW, Moffat GT, O\u2019Donnell CDJ, Ding PQ, Lyubetska H, Meyers BM, Gordon V, Kosyachkova E, Bucur R, Cheung WY, Knox JJ, Tam VC. Real-world outcomes of Atezolizumab with bevacizumab treatment in hepatocellular carcinoma patients: effectiveness, esophagogastroduodenoscopy utilization and bleeding complications. Cancers (Basel). 2024;16:2878.","journal-title":"Cancers (Basel)."},{"key":"9776_CR9","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.3390\/cancers15092480","volume":"15","author":"CW-K Wu","year":"2023","unstructured":"Wu CW-K, Lui RN-S, Wong VW-S et al. Baveno VII criteria is an accurate risk stratification tool to predict high-risk varices requiring intervention and hepatic events in patients with advanced hepatocellular carcinoma. Cancers 2023;15:2480.","journal-title":"Cancers"},{"key":"9776_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/apt.17599","volume":"58","author":"M Allaire","year":"2023","unstructured":"Allaire M, Campion B, Demory A et al. Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma. Aliment Pharmacol Ther. 2023;58:56. https:\/\/doi.org\/10.1111\/apt.17599.","journal-title":"Aliment Pharmacol Ther."},{"key":"9776_CR11","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s12325-019-00967-w","volume":"36","author":"X Qi","year":"2019","unstructured":"Qi X, Li Y, Wang R et al. Liaoning score for prediction of esophageal varices in cirrhotic patients who had never undergone endoscopy: a multicenter cross-sectional study in Liaoning Province. China. Adv Ther 2019;36:2167\u20132178. https:\/\/doi.org\/10.1007\/s12325-019-00967-w.","journal-title":"China. Adv Ther"},{"key":"9776_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.21037\/atm.2019.11.78","volume":"7","author":"Q Li","year":"2019","unstructured":"Li Q, Wu Y, Zhu Q et al. External validation of Liaoning score for predicting esophageal varices in liver cirrhosis: a Chinese multicenter cross-sectional study. Ann Transl Med. 2019;7:755.","journal-title":"Ann Transl Med."},{"key":"9776_CR13","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.12659\/MSM.895005","volume":"20","author":"H Deng","year":"2015","unstructured":"Deng H, Qi X, Peng Y et al. Diagnostic accuracy of APRI, AAR, FIB-4, FI, and king scores for diagnosis of esophageal varices in liver cirrhosis: a retrospective study. Med Sci Monit. 2015;20:3961\u20133977.","journal-title":"Med Sci Monit."},{"key":"9776_CR14","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1007\/s10620-024-08449-y","volume":"69","author":"JO Yang","year":"2024","unstructured":"Yang JO, Chittajallu P, Benhammou JN et al. Validation of a machine learning algorithm, EVendo, for predicting esophageal varices in hepatocellular carcinoma. Dig Dis Sci. 2024;69:3079\u20133084. https:\/\/doi.org\/10.1007\/s10620-024-08449-y.","journal-title":"Dig Dis Sci."},{"key":"9776_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12885-020-07708-1","volume":"21","author":"J Lim","year":"2021","unstructured":"Lim J, Kim HI, Kim E et al. Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study. BMC Cancer 2021;21:11. https:\/\/doi.org\/10.1186\/s12885-020-07708-1.","journal-title":"BMC Cancer"},{"key":"9776_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gie.2017.12.023","volume":"88","author":"Ping-Hsien Chen","year":"2018","unstructured":"Chen Ping-Hsien, Hsieh Wei-Yao, Chien-Wei Su et al. Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma\u00a0who does not require endoscopic screening for esophageal varices. Gastrointest Endosc. 2018;88:230\u2013239.","journal-title":"Gastrointest Endosc."},{"key":"9776_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1200\/JCO.2025.43.4_suppl.587","volume":"43","author":"Masafumi Ikeda","year":"2025","unstructured":"Ikeda Masafumi et al. A multicenter, phase 2 study of atezolizumab plus bevacizumab (atezo+bev) combination therapy in patients with unresectable hepatocellular carcinoma (HCC) and Child-pugh class B cirrhosis: challenge trial final results. JCO 2025;43:587\u2013587. https:\/\/doi.org\/10.1200\/JCO.2025.43.4_suppl.587.","journal-title":"JCO"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09776-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09776-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09776-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:53:56Z","timestamp":1786017236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09776-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["9776"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09776-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board of SingHealth granted ethical approval for this study (2018\/3046). All patients have given their written informed consent.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}